U.S. Markets closed

OptiNose, Inc. (OPTN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.2000+0.0800 (+2.56%)
At close: 4:00PM EDT
Sign in to post a message.
  • P
    Patrick Brian
    Oversold - Look at bollinger band out of the spread bottom level and RSI 17. Again Buy before it is too late!!!
  • M
    Mr wolf
    OptiNose, Inc. director just picked up 10,000 shares . Finally some insider buying.
  • Y
    Yahoo Finance Insights
    OptiNose is up 5.84% to 3.08
  • P
    Patrick Brian
    The most undervalued Small cap Biotech stock!!
    Bullish
  • M
    Mr wolf
    New institutions opening new positions...after Q2 report we should be north of $4 heading to $5. We need the big dogs to start buying to neutralize the shorts.
    Bullish
  • P
    Patrick Brian
    Screaming buy!!
    Bullish
  • M
    Mr wolf
    Really disappointed with the reaction to Q1 ..another bloody day ...one thing left for me ...Add more and stay strong 💪. Go longs
  • j
    john
    What would be the catalyst to buy for?
  • M
    Ma
    I bought in. But only 100 shares. Sorry guys. 🙏
  • A
    Andrew
    CEO Insider Buy at $3.90 on 3/18. Google Guru Insider Trades. Yahoo won't let me paste link.
  • M
    Mr wolf
    Hope market is green , plus some good update in order to take out some shorts with higher volume and price 🤞🚀💎🚀
    Bullish
  • R
    Richard Thomas
    Off the radar opportunity. Short term will steadily wiggle upward though longish term is the play.
  • M
    Mr wolf
    Big Run coming 🚀🚀🚀OPN-019
    The company also is combining its EDS technology with an antiseptic for the treatment of COVID-19. In vitro testing demonstrated a 99.99% reduction in virus count. Initial release of the preclinical results caused a brief spike in OPTN shares to $10 in June 2020. The company expects to initiate a randomized, proof of concept study in subjects who have tested positive for SARS-CoV-2 infection, are recently infected, and who have mild or no symptoms in Mexico this April.
  • S
    SuffolkNick
    OPTN is being shorted ....it's a pity #WallStreetBets doesn't pick up on this! Optinose has 2 great products: XHANCE® (fluticasone propionate) for nasal polyps and multiple congestion symptoms and licensed ONZETRA® Xsail® for migraine. Plus more on the horizon including an antiseptic nasal spray that works to prevent Coronavirus by neutralizing virus as it enters via the nose/mouth airways, initial trials show 99.9% ness.

    The inhaler application system could be also be explored as a delivery mechanism to administer other drugs and vaccines that might benefit from nasal application! Has to be a #BUY
  • P
    Patrick Brian
    Nobody noticed 357 neg nasdaq and dow -681 optn up +6.19!
  • M
    Mr wolf
    Low volume and some weak hands, leads to this fake walls created by shorts to depress the uptrend. Set limit sell to $50 don’t let shorts borrow your shares. 🙌💎🙌🔥🔥🔥🔥
  • M
    Mike T
    $17 target still intact.
  • A
    Andrew
    5M shares short. 10X Daily volume. Ouch.....
  • A
    Andrew
    Will POP today.
    "The Company has performed in vitro testing against SARS-CoV-2 with a candidate formulation in which a 4-log reduction (a 99.99% reduction) in virus count was produced. In addition, the Company performed tests against other pathogens. For most pathogens tested, 3-log to 6-log reductions (99.9% to 99.9999% reductions) in virus count were observed.

    In April 2021, the Company expects to initiate a randomized, proof of concept study in subjects who have tested positive for SARS-CoV-2 infection, are recently infected, and who have mild or no symptoms. This pilot study being conducted in Mexico will evaluate both the magnitude and duration of viral load reduction after a single dose of OPN-019. The Company expects top-line results from this study in second quarter 2021.
  • A
    Andrew
    High volume and big bump A/H last night.
    Today, bigger move up on some volume.
    Do we have news pending???